ITC Share Analysis: Buy or Sell at Rs. 266.40?
ITC at Rs. 266.40 merits a Hold and selective accumulation view for 9–12 months, rather than an aggressive purchase or panic exit. Dividend income supports the investment case, but declining cigarette profitability and an incomplete technical recovery demand patience.
Q2 Results: Look Beyond Revenue Growth
The September-quarter figures indicate approximately 19% lower consolidated profit despite reported revenue growth of 43.9%. Crucially, higher excise duty inflated reported revenue. After deducting duty, revenue increased approximately 3.9%, offering a clearer indication of underlying expansion.
Cigarette segment profit declined 26%, outweighing improvement elsewhere. Other FMCG revenue increased 19.1%, while segment profit rose 31.4%. However, inclusion of Sproutlife affects comparability; investors should distinguish acquisition effects from organic growth.
The accompanying screener table and news extract contain different profit and sales figures. These should not be combined into one earnings comparison without reconciling reporting periods, consolidation and profit attribution.
Earlier Performance Provides Context
ITC’s official FY26 commentary reported standalone gross revenue growth of 10.1% and EBITDA growth of 4.9%. The weaker latest quarter therefore raises a meaningful question: how quickly can cigarette earnings stabilise after the tax changes?
The investment snapshot shows five-year sales and profit growth near 9.9% and 9.6%, respectively. Its almost debt-free position provides resilience, but historical growth cannot offset persistent deterioration in its largest profit contributor.
Dividend Yield: Attractive, With Conditions
ITC paid Rs. 14.50 per share for FY26, comprising Rs. 6.50 interim and Rs. 8 final dividend. At Rs. 266.40, this represents a historical yield of approximately 5.44%.
If the same annual dividend were maintained, 1,000 shares would generate Rs. 14,500 before tax. Future dividends remain dependent on earnings, cash requirements and board decisions. Previous payouts are not an entitlement for new buyers.
The quoted 74.5% payout and three-year ROE of 35.2% provide context, but their measurement bases need checking against current continuing operations.
Technical Trend: Recovery Needs Confirmation
Price is above the 5, 10, 20 and 50-day averages, with nearby references clustered around Rs. 262–264.
However, Rs. 273.96 and Rs. 291.36, the 100-day and 200-day averages, remain overhead hurdles. RSI of 54.50 suggests improving momentum; MACD remains negative and ADX of 20.19 indicates limited trend strength.
Session volume was only 31.6% of its monthly average, weakening conviction. Overbought Williams %R also argues against chasing.
Chanakya View and Rating
Rating: Three-star conditional opportunity. Existing investors with manageable exposure can hold while monitoring cigarette earnings and cash generation.
Fresh investors may consider small, staggered purchases after stabilisation around Rs. 258–264, retaining funds for later confirmation. These are proposed planning levels, not verified chart supports.
For 9–12 months, Rs. 290–300 is a conditional recovery zone, offering approximately 8.9–12.6% price appreciation from CMP. Adding an unchanged annual dividend gives an illustrative 14.3–18.1% gross total return, not a forecast.
Reassess below Rs. 250, or earlier if earnings weaken further. Dividend seekers can accumulate cautiously; investors needing rapid capital appreciation should wait for stronger confirmation. Position sizing should reflect this uncertainty.
Quicklinks